1
0

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

3/20/2026, 8:06 AM

Summary of Bill HR 8005

H.R. 8005, introduced in the 119th Congress on March 19, 2026, aims to amend the Controlled Substances Act to restrict specific activities concerning fentanyl, fentanyl analogues, and counterfeit substances.

Current Status of Bill HR 8005

Bill HR 8005 is currently in the status of Bill Introduced since March 19, 2026. Bill HR 8005 was introduced during Congress 119 and was introduced to the House on March 19, 2026.  Bill HR 8005's most recent activity was Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 19, 2026

Bipartisan Support of Bill HR 8005

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8005

Primary Policy Focus

Alternate Title(s) of Bill HR 8005

To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.
To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.

Comments